Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.6 USD | -1.88% | -8.05% | -20.28% |
05-02 | RBC Capital Reviews Bausch + Lomb's Q1 Results | MT |
05-02 | Deutsche Bank Adjusts Bausch + Lomb Price Target to $14 From $18, Maintains Hold Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.28% | 4.78B | |
-3.79% | 184B | |
-0.84% | 108B | |
-3.75% | 67.82B | |
+3.45% | 51.05B | |
+9.04% | 44.67B | |
+3.40% | 41.78B | |
+3.21% | 26.78B | |
+3.66% | 26.59B | |
+15.23% | 25.86B |
- Stock Market
- Equities
- BLCO Stock
- News Bausch + Lomb Corporation
- Bausch + Lomb Brief: Says Will Present New Scientific Data and Analyses During the American Academy of Ophthalmology Annual Meeting